1. Home
  2. PLAB vs AMPH Comparison

PLAB vs AMPH Comparison

Compare PLAB & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • AMPH
  • Stock Information
  • Founded
  • PLAB 1969
  • AMPH 1996
  • Country
  • PLAB United States
  • AMPH United States
  • Employees
  • PLAB N/A
  • AMPH N/A
  • Industry
  • PLAB Semiconductors
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • AMPH Health Care
  • Exchange
  • PLAB Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • PLAB 1.3B
  • AMPH 1.1B
  • IPO Year
  • PLAB 1987
  • AMPH 2014
  • Fundamental
  • Price
  • PLAB $19.54
  • AMPH $24.65
  • Analyst Decision
  • PLAB Strong Buy
  • AMPH Buy
  • Analyst Count
  • PLAB 1
  • AMPH 4
  • Target Price
  • PLAB $35.00
  • AMPH $40.67
  • AVG Volume (30 Days)
  • PLAB 643.3K
  • AMPH 578.6K
  • Earning Date
  • PLAB 05-21-2025
  • AMPH 05-07-2025
  • Dividend Yield
  • PLAB N/A
  • AMPH N/A
  • EPS Growth
  • PLAB 5.99
  • AMPH N/A
  • EPS
  • PLAB 2.35
  • AMPH 2.77
  • Revenue
  • PLAB $862,750,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • PLAB $2.60
  • AMPH $2.32
  • Revenue Next Year
  • PLAB $6.56
  • AMPH $6.60
  • P/E Ratio
  • PLAB $8.12
  • AMPH $8.99
  • Revenue Growth
  • PLAB N/A
  • AMPH 8.05
  • 52 Week Low
  • PLAB $16.46
  • AMPH $22.64
  • 52 Week High
  • PLAB $31.60
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 56.37
  • AMPH 47.33
  • Support Level
  • PLAB $18.59
  • AMPH $23.69
  • Resistance Level
  • PLAB $19.42
  • AMPH $25.37
  • Average True Range (ATR)
  • PLAB 0.46
  • AMPH 0.83
  • MACD
  • PLAB 0.24
  • AMPH 0.25
  • Stochastic Oscillator
  • PLAB 92.59
  • AMPH 71.54

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: